Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025Business Wire • 10/26/25
Colon Cancer Screening Leader Guardant Health Tests Buy Point As Earnings LoomInvestors Business Daily • 10/21/25
S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile MarketInvestors Business Daily • 10/18/25
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025Business Wire • 10/15/25
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025Business Wire • 10/09/25
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast CancerBusiness Wire • 09/29/25
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United StatesBusiness Wire • 09/24/25
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida PartnershipBusiness Wire • 09/11/25
Guardant Health, Inc. (GH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 StatesBusiness Wire • 09/08/25
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening TestBusiness Wire • 09/04/25
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceBusiness Wire • 08/26/25
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health EquityBusiness Wire • 08/04/25
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth ConferenceBusiness Wire • 07/31/25
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 EarningsBenzinga • 07/31/25
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/31/25
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue GuidanceBusiness Wire • 07/30/25
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+Business Wire • 07/30/25